Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Thevis et al., Characterization of a nonapproved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phaseI metabolites for human sports drug testing, Rapid Communications in Mass Spectrometry, vol
A travel fee may apply for some locations, and many clients use HSA or FSA funds
"TB-500 as a potential treatment for musculoskeletal injury." Front Pharmacol
Los resultados individuales varan segn el perfil del paciente, la dosis y el abordaje global
US$ 28.07
US$ 26.09
US$ 21.08
US$ 28.31
